These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28248754)

  • 1. Patterns of testosterone prescription overuse.
    Jasuja GK; Bhasin S; Rose AJ
    Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):240-245. PubMed ID: 28248754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone therapy: where do the latest guidelines agree and differ?
    Pelzman DL; Hwang K
    Curr Opin Endocrinol Diabetes Obes; 2020 Dec; 27(6):397-403. PubMed ID: 33044244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in testosterone prescription during the release of society guidelines.
    Sellke N; Omil-Lima D; Sun HH; Tay K; Rhodes S; Loeb A; Thirumavalavan N
    Int J Impot Res; 2024 Jun; 36(4):380-384. PubMed ID: 37130972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global trends in testosterone prescribing, 2000-2011: expanding the spectrum of prescription drug misuse.
    Handelsman DJ
    Med J Aust; 2013 Oct; 199(8):548-51. PubMed ID: 24138381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Testosterone Prescribing for Age-related Hypogonadism in Men With and Without Heart Disease.
    Morden NE; Woloshin S; Brooks CG; Schwartz LM
    JAMA Intern Med; 2019 Mar; 179(3):446-448. PubMed ID: 30592484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Quetiapine Overuse Letters With Prescribing by Physician Peers of Targeted Recipients: A Secondary Analysis of a Randomized Clinical Trial.
    Sacarny A; Olenski AR; Barnett ML
    JAMA Psychiatry; 2019 Oct; 76(10):1094-1095. PubMed ID: 31162529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study.
    Jasuja GK; Bhasin S; Reisman JI; Hanlon JT; Miller DR; Morreale AP; Pogach LM; Cunningham FE; Park A; Berlowitz DR; Rose AJ
    J Gen Intern Med; 2017 Mar; 32(3):304-311. PubMed ID: 27995426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High volume of opioid prescribing and the apparent consequences.
    Mendes A
    Br J Community Nurs; 2020 Jan; 25(1):48-49. PubMed ID: 31874083
    [No Abstract]   [Full Text] [Related]  

  • 9. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
    Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
    Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marketing and Testosterone Treatment in the USA: A Systematic Review.
    Bandari J; Ayyash OM; Emery SL; Wessel CB; Davies BJ
    Eur Urol Focus; 2017 Oct; 3(4-5):395-402. PubMed ID: 29174614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "pharmaceuticalisation" of life.
    Braillon A; Lexchin J; Blumsohn A; Hengartner MP
    BMJ; 2019 May; 365():l1972. PubMed ID: 31068329
    [No Abstract]   [Full Text] [Related]  

  • 12. Testosterone prescribing in men with depression and anxiety disorders.
    Javed Z; Kuo YF; Temple JR; Urban RJ; Holmes H; Baillargeon J
    Ann Epidemiol; 2020 Oct; 50():15-19.e8. PubMed ID: 32800673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. That Was Then, This Is Now: Using Palliative Care Principles to Guide Opioid Prescribing.
    Chai E; Goldhirsch S
    J Palliat Med; 2019 Jun; 22(6):612-614. PubMed ID: 31158054
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypogonadism is not being sufficiently recognised in 99% of general practices/family doctor surgeries.
    Stedman M; Livingston M; Albanese M; Hackett G; Heald AH
    Int J Clin Pract; 2020 Feb; 74(2):e13445. PubMed ID: 31713967
    [No Abstract]   [Full Text] [Related]  

  • 15. Doctors are urged to limit opioid prescribing.
    McCarthy M
    BMJ; 2016 Mar; 352():i1614. PubMed ID: 26993363
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends and Patterns of Testosterone Therapy among U.S. Male Medicare Beneficiaries, 1999 to 2014.
    Zhou CK; Advani S; Chaloux M; Gibson JT; Yu M; Bradley M; Hoover RN; Cook MB
    J Urol; 2020 Jun; 203(6):1184-1190. PubMed ID: 31928462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Testosterone Prescription and Public Health Concerns.
    Gabrielsen JS; Najari BB; Alukal JP; Eisenberg ML
    Urol Clin North Am; 2016 May; 43(2):261-71. PubMed ID: 27132584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of opioid prescribing guidelines on prescribing at discharge from endocrine surgery.
    Sada A; Glasgow AE; Dy BM; Lyden ML; Thompson GB; McKenzie TJ; Habermann EB
    Am J Surg; 2021 Feb; 221(2):455-459. PubMed ID: 32847688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Illusory Case for Treatment of an Invented Disease.
    Handelsman DJ
    Front Endocrinol (Lausanne); 2021; 12():682620. PubMed ID: 35116001
    [No Abstract]   [Full Text] [Related]  

  • 20. Testosterone prescribing in UK general practice: Are patients being monitored correctly for associated risks whilst on treatment?
    Castle G; Stammers J
    Basic Clin Pharmacol Toxicol; 2020 Nov; 127(5):434-437. PubMed ID: 32472733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.